Click here to see an annotated bibliography of the data in the table.
This is a table of authors, titles, dates and other bibliographic information; it is a list metadata describing the content of your study carrel. Think of it as your library.
| id | author | title | date | words | sentences | text |
|---|---|---|---|---|---|---|
| cord-285486-99trkti1 | Abd-Elsalam, Sherief | Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study | 2020-08-14 | 2928.0 | 166.0 | view text |
| cord-347186-tbtmqmpr | Acharya, Yogesh | Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review | 2020-08-04 | nan | nan | view text |
| cord-293304-kakxmc14 | Achutha, A. S. | Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors | 2020-09-22 | nan | nan | view text |
| cord-304669-aiuiotds | Afsin, Abdulmecit | Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19 | 2020-08-15 | nan | nan | view text |
| cord-326154-01es0zv4 | Aggarwal, Gaurav | Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019 | 2020-05-16 | nan | nan | view text |
| cord-262193-p7foay4k | Ahmad, I. | Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities | 2020-05-22 | 2468.0 | 157.0 | view text |
| cord-256294-9gmn4fcj | Almazrou, Saja H. | Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study | 2020-10-01 | 3011.0 | 183.0 | view text |
| cord-306351-ka6asw3m | Alsuliman, Tamim | A review of potential treatments to date in COVID-19 patients according to the stage of the disease | 2020-05-30 | nan | nan | view text |
| cord-348987-3jpdvy7n | Annangi, Srinadh | Chloroquine and hydroxychloroquine for COVID‐19: A word of caution | 2020-05-11 | 844.0 | 51.0 | view text |
| cord-351510-8m4930bc | Aquino, Yves S J | Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making | 2020-07-09 | nan | nan | view text |
| cord-290955-m2igkcxv | Asli, Rosmonaliza | Case Report: Right Bundle Brunch Block and QTc Prolongation in a Patient with Novel Coronavirus Disease (COVID-19) Treated with Hydroxychloroquine | 2020-05-07 | nan | nan | view text |
| cord-274545-r03g7w0b | Ayele Mega, Teshale | The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis | 2020-10-13 | 6277.0 | 376.0 | view text |
| cord-275041-fcdwitxy | Ayerbe, Luis | The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients | 2020-09-30 | 3258.0 | 171.0 | view text |
| cord-297010-imciixde | Babayeva, Mariana | Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine | 2020-10-23 | nan | nan | view text |
| cord-344120-7t5ce2hb | Baroutjian, Amanda | SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence | 2020-09-01 | 5264.0 | 336.0 | view text |
| cord-340090-dqhdws5k | Behera, P. | Role of ivermectin in the prevention of COVID-19 infection among healthcare workers in India: A matched case-control study | 2020-11-03 | nan | nan | view text |
| cord-286579-u87lx38h | Biguetti, Claudia | Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)? | 2020-06-26 | nan | nan | view text |
| cord-259957-temt8b6f | Brown, Ronald | Hydroxychloroquine and “off-label” utilization in the treatment of oral conditions | 2020-04-11 | 861.0 | 55.0 | view text |
| cord-028530-hpgrbhkl | Cairoli, Ernesto | Hydroxychloroquine in the treatment of COVID-19: how to use it waiting for conclusive scientific evidence() | 2020-07-04 | 852.0 | 59.0 | view text |
| cord-259663-fjvumaby | Carvalho, Alzira Alves de Siqueira | Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative Review | 2020-10-31 | 2738.0 | 155.0 | view text |
| cord-275037-sji0u8nu | Cavalli, Giulio | Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness | 2020-10-28 | 871.0 | 45.0 | view text |
| cord-262467-epqqd8n8 | Chen, Jun | COVID-19 infection: the China and Italy perspectives | 2020-06-08 | 7596.0 | 384.0 | view text |
| cord-031079-9lxhvyyb | Chen, Li | The effects of chloroquine and hydroxychloroquine on ACE2 related coronavirus pathology and the cardiovascular system: An evidence based review | 2020-07-27 | 5660.0 | 354.0 | view text |
| cord-278068-3kg71nf4 | Chivese, T. | A meta-review of systematic reviews and an updated meta-analysis on the efficacy of chloroquine and hydroxychloroquine in treating COVID19 infection | 2020-07-30 | nan | nan | view text |
| cord-317624-qdzhncs0 | Choi, Min Joo | Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study | 2020-10-27 | 4287.0 | 228.0 | view text |
| cord-337198-4sors3bg | Clementi, Nicola | Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro | 2020-07-10 | 4259.0 | 224.0 | view text |
| cord-341377-mjdg84ny | Cohen, I. V. | Determinants of cardiac adverse events of chloroquine and hydroxychloroquine in 20 years of drug safety surveillance reports | 2020-05-26 | nan | nan | view text |
| cord-286413-a7wue2e3 | Cohen, Isaac V. | Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports | 2020-11-05 | nan | nan | view text |
| cord-303819-w1785lap | Cortegiani, Andrea | Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19 | 2020-07-11 | nan | nan | view text |
| cord-315864-zadogqiu | Davido, Benjamin | nImpact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time | 2020-08-02 | nan | nan | view text |
| cord-283903-e20v88ge | Davoodi, Lotfollah | Febuxostat therapy in outpatients with suspected COVID‐19: A clinical trial | 2020-06-30 | 3121.0 | 194.0 | view text |
| cord-320499-76o2zj0v | Davoodi, Lotfollah | Hydroxychloroquine-induced Stevens–Johnson syndrome in COVID-19: a rare case report | 2020-06-25 | nan | nan | view text |
| cord-327006-m847xdzk | Di Castelnuovo, A. | Low dose hydroxychloroquine is associated with lower mortality in COVID-19: a meta-analysis of 26 studies and 44,521 patients | 2020-11-04 | nan | nan | view text |
| cord-268425-xg8xnjf9 | DiNicolantonio, James J. | Harnessing Adenosine A2A Receptors as a Strategy for Suppressing the Lung Inflammation and Thrombotic Complications of COVID-19: Potential of Pentoxifylline and Dipyridamole | 2020-07-02 | nan | nan | view text |
| cord-287680-vdrix1cp | D’Acquarica, Ilaria | Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19 | 2020-05-01 | 1176.0 | 75.0 | view text |
| cord-327360-4qpk99x9 | Elsawah, Hozaifa Khalil | Hydroxychloroquine for treatment of non‐severe COVID‐19 patients; systematic review and meta‐analysis of controlled clinical trials | 2020-08-18 | nan | nan | view text |
| cord-288311-8kcturbn | Fassihi, Safa C. | Novel Approach for Low‐Dose Pulmonary Delivery of Hydroxychloroquine in COVID‐19 | 2020-06-19 | 1536.0 | 86.0 | view text |
| cord-267762-mzon01fd | Ferreira, A. | Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection. | 2020-06-29 | 2939.0 | 167.0 | view text |
| cord-270723-cjfglili | Fteiha, Bashar | QTc prolongation among hydroxychloroquine sulfate‐treated COVID‐19 patients: An observational study | 2020-10-15 | 3317.0 | 191.0 | view text |
| cord-347731-eqxn6auk | Garcia‐Cremades, Maria | Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing | 2020-05-12 | nan | nan | view text |
| cord-281411-la8njxc1 | García-Fernández, Amaya | Utilidad y seguridad de la automonitorización electrocardiográfica durante el tratamiento con hidroxicloroquina y azitromicina en pacientes con COVID-19 | 2020-10-01 | 1264.0 | 89.0 | view text |
| cord-257144-3q0un5rl | Giri, Allan | Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19 | 2020-09-02 | 5580.0 | 285.0 | view text |
| cord-253609-vi2fb43t | Gopinathannair, Rakesh | COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies | 2020-06-03 | 3198.0 | 176.0 | view text |
| cord-261186-4p1cwb2e | Guzman-Prado, Yuli | Recent findings on cardiovascular safety with the use of chloroquine and hydroxychloroquine for COVID-19. | 2020-06-09 | nan | nan | view text |
| cord-272296-1gn1zhvt | HUYBRECHTS, Krista F. | Hydroxychloroquine early in Pregnancy and Risk of Birth Defects | 2020-09-19 | 4618.0 | 227.0 | view text |
| cord-341101-5yvjbr5q | Hashem, Anwar M. | Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review | 2020-05-06 | 4823.0 | 275.0 | view text |
| cord-321337-tg8kfiot | Hulme, Oliver J | A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19 | 2020-04-03 | 5372.0 | 282.0 | view text |
| cord-278246-mnj0zmkn | Hussain, Nowair | A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19 | 2020-08-24 | 2986.0 | 170.0 | view text |
| cord-268453-87b298uk | Ibáñez, Sebastián | Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? | 2020-06-03 | 3500.0 | 150.0 | view text |
| cord-312875-gn6hg6oc | Infante, Marco | Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: risks and benefits at the time of COVID‐19 pandemic | 2020-05-13 | 4839.0 | 291.0 | view text |
| cord-329920-s928u6g3 | Isaksen, J. L. | Chloroquine, but not hydroxychlorquine, prolongs the QT interval in a primary care population | 2020-06-20 | nan | nan | view text |
| cord-026811-6bdzut3d | Jha, Ashish K. | Emerging Treatment and Prevention Strategies against COVID-19: A Brief Update | 2020-05-16 | 2684.0 | 148.0 | view text |
| cord-317561-ewo6vvlr | Jha, Sujeet | HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers | 2020-11-10 | nan | nan | view text |
| cord-288017-f9b3t0ts | Kabeerdoss, Jayakanthan | Understanding immunopathological fallout of human coronavirus infections including COVID‐19: Will they cross the path of rheumatologists? | 2020-08-10 | nan | nan | view text |
| cord-336572-n6juf8tw | Kalligeros, Markos | Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study | 2020-08-05 | nan | nan | view text |
| cord-347775-hidb8q1u | Karatza, Eleni | Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients’ characteristics: a review of the literature and simulations | 2020-09-30 | 5968.0 | 300.0 | view text |
| cord-286038-a62k3lma | Klimke, A. | Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection | 2020-04-27 | nan | nan | view text |
| cord-324166-6ydn2bvy | Kumar, Neeraj | Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis | 2020-08-20 | 5482.0 | 284.0 | view text |
| cord-342746-2hbcbvt6 | Lane, J. C. E. | Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study | 2020-04-10 | nan | nan | view text |
| cord-354653-m0717ywt | Leung, Alexander KC | Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus | 2020-07-20 | nan | nan | view text |
| cord-253513-zn87f1lk | Liu, Jia | Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro | 2020-03-18 | 2370.0 | 121.0 | view text |
| cord-293159-oagv4q1u | Liu, Peng | Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses | 2020-07-08 | nan | nan | view text |
| cord-029882-kufs0fxe | Malviya, Amit | The continued dilemma about usage of Hydroxychloroquine: Respite is in randomized control trials | 2020-07-29 | 483.0 | 34.0 | view text |
| cord-315598-qwh72inx | Mendoza, Jose Luis Accini | ACTUALIZACION DE LA DECLARACIÓN DE CONSENSO EN MEDICINA CRITICA PARA LA ATENCIÓN MULTIDISCIPLINARIA DEL PACIENTE CON SOSPECHA O CONFIRMACIÓN DIAGNÓSTICA DE COVID-19 | 2020-10-06 | 69640.0 | 6489.0 | view text |
| cord-323647-q67fa0m3 | Misra, Durga Prasanna | Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates | 2020-09-02 | nan | nan | view text |
| cord-324707-9ld73wv1 | Mitjà, Oriol | Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial | 2020-07-16 | 4268.0 | 263.0 | view text |
| cord-272419-y3ebt4jm | Monari, Caterina | A Focus on the Nowadays Potential Antiviral Strategies in Early Phase of Coronavirus Disease 2019 (Covid-19): A Narrative Review | 2020-08-09 | nan | nan | view text |
| cord-339669-p61j2caf | Monzani, Alice | QTc evaluation in COVID‐19 patients treated with chloroquine/hydroxychloroquine | 2020-05-18 | nan | nan | view text |
| cord-327575-5pcnuqgy | Morrisette, Taylor | The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse | 2020-08-01 | nan | nan | view text |
| cord-316992-fe5u2oi0 | Nirk, Eliise Laura | Hydroxychloroquine in rheumatic autoimmune disorders and beyond | 2020-07-26 | 10114.0 | 464.0 | view text |
| cord-328714-jg562twk | Oscanoa, Teodoro J. | Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: a Meta-analysis | 2020-10-24 | nan | nan | view text |
| cord-339717-2a8zv9xl | O’Connell, Thomas F. | Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients with COVID-19 | 2020-08-05 | nan | nan | view text |
| cord-332654-nav15g8k | Paniri, Alireza | Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations | 2020-08-04 | 5712.0 | 341.0 | view text |
| cord-349868-lb2jcl8m | Patel, Jay | Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review | 2020-07-12 | 2350.0 | 125.0 | view text |
| cord-303968-ikr6eeov | Perinel, Sophie | Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients | 2020-04-07 | nan | nan | view text |
| cord-268519-t15yvy5s | Pothen, Lucie | Safety use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center | 2020-06-12 | 538.0 | 40.0 | view text |
| cord-307570-8f83k2ce | Prodromos, Chadwick | Hydroxychloroquine is effective, and consistently so used early, for Covid-19: A systematic review | 2020-10-05 | nan | nan | view text |
| cord-318092-errwp80i | Ren, L. | Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis | 2020-05-08 | 5938.0 | 371.0 | view text |
| cord-255690-xc4bxin4 | Rolain, Jean-Marc | Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century | 2007-07-16 | 7020.0 | 351.0 | view text |
| cord-350992-l6l24pco | Roldan, Eugenia Quiros | The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? | 2020-05-13 | 8037.0 | 393.0 | view text |
| cord-283064-ncyhvkwl | Rowland Yeo, Karen | Impact of disease on plasma and lung exposure of chloroquine, hydroxy‐chloroquine and azithromycin: application of PBPK modelling | 2020-06-12 | nan | nan | view text |
| cord-270290-i4p4p0o4 | Ruamviboonsuk, Paisan | Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19 | 2020-04-29 | 1716.0 | 91.0 | view text |
| cord-260857-oxxle915 | Samuel, Sharmeen | INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC ABNORMALITIES IN SYMPTOMATIC PEDIATRIC PATIENTS WITH PCR POSITIVE SARS-CoV-2 INFECTION INCLUDING DRUG INDUCED CHANGES IN THE CORRECTED QT INTERVAL (QTc). | 2020-07-01 | 4183.0 | 217.0 | view text |
| cord-262780-ilu5oskk | Sattui, Sebastian E. | Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19 | 2020-08-11 | 4653.0 | 251.0 | view text |
| cord-339737-7qdjea6f | Sbidian, E. | Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France | 2020-06-19 | 6035.0 | 306.0 | view text |
| cord-296649-h6oyjz56 | Scherf-Clavel, Oliver | Tissue Level Profiling of SARS-CoV-2 antivirals in mice to predict their effects: comparing Remdesivir’s active metabolite GS-441 524 vs. the clinically failed Hydroxychloroquine | 2020-11-06 | 5076.0 | 263.0 | view text |
| cord-319571-fspmgg4s | Sehailia, Moussa | Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19 | 2020-07-22 | 4894.0 | 232.0 | view text |
| cord-317761-tkqmu1va | Shukla, Ashutosh M | Chloroquine and hydroxychloroquine in the context of COVID-19 | 2020-04-28 | nan | nan | view text |
| cord-333144-gyuh2fvl | Siddiqui, Arif Jamal | Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2 | 2020-08-05 | 7806.0 | 436.0 | view text |
| cord-281285-5g1rw202 | Simonis, Alexander | A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2 | 2020-11-03 | nan | nan | view text |
| cord-295973-41jqgsv0 | Singh, Awadhesh Kumar | Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries | 2020-03-26 | nan | nan | view text |
| cord-026340-2nf97zvc | Singh, Ranjana | Chloroquine: A Potential Drug in the COVID-19 Scenario | 2020-06-07 | 7542.0 | 412.0 | view text |
| cord-277916-b4yqek29 | Sridhar, Arun R. | QT Interval and Arrhythmic Safety of Hydroxychloroquine Monotherapy in Coronavirus Disease 2019 | 2020-06-11 | nan | nan | view text |
| cord-295144-tyyc81uc | Stradner, Martin H. | Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic | 2020-10-09 | nan | nan | view text |
| cord-353749-2vlc11rx | Stricker, Raphael B | Flattening the Risk: Pre-Exposure Prophylaxis for COVID-19 | 2020-10-19 | 3090.0 | 200.0 | view text |
| cord-275340-q8d7rvnj | Sun, JingKang | Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19 | 2020-06-21 | 6629.0 | 285.0 | view text |
| cord-262454-bccrvapy | Szente Fonseca, Silvia Nunes | Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens in Brazil: Comparative Analysis | 2020-10-31 | nan | nan | view text |
| cord-280528-7ivw72l0 | TUFAN, Abdurrahman | COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs | 2020-04-21 | nan | nan | view text |
| cord-258684-lq4knxgf | Takano, Tomomi | Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection | 2020-05-24 | 3704.0 | 236.0 | view text |
| cord-352557-l7sahv5t | Takla, Michael | Chloroquine, hydroxychloroquine, and COVID-19: systematic review and narrative synthesis of efficacy and safety | 2020-11-13 | nan | nan | view text |
| cord-289916-rgvcimk3 | Tleyjeh, Imad M. | The Cardiac Toxicity of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-regression Analysis | 2020-11-02 | nan | nan | view text |
| cord-289091-djv4syy4 | Ullah, Waqas | Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis | 2020-07-04 | nan | nan | view text |
| cord-339838-8okrjbfn | Wang, Ya‐Ling | Pharmacist''s perspective on HCQ treatment of COVID‐19 | 2020-06-12 | 329.0 | 25.0 | view text |
| cord-277555-tsd6npma | Wilde, A. A. M. | The ‘president’s drug’ | 2020-07-10 | 1685.0 | 85.0 | view text |
| cord-328257-kl4wh2zg | Xu, H | Hydroxychloroquine increased psychiatric-like behaviors and disrupted the expression of related genes in the mouse brain | 2020-09-28 | nan | nan | view text |
| cord-293428-8hj06hzt | Yang, Jianling | Cytotoxicity evaluation of chloroquine and hydroxychloroquine in multiple cell lines and tissues by dynamic imaging system and PBPK model | 2020-04-24 | nan | nan | view text |
| cord-253196-et1ekgdl | Yazdany, Jinoos | Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know | 2020-03-31 | 1330.0 | 70.0 | view text |
| cord-024786-f33eb1nf | van Rensburg, V | Current evidence for directed and supportive investigational therapies against COVID-19 | 2020-04-24 | 4411.0 | 279.0 | view text |